Psilocybin halts chemotherapy-induced nerve pain in mice

In mice, two pre-chemo doses of psilocybin prevented peripheral neuropathy across six chemotherapy rounds by activating receptors on sensory nerves to keep mitochondria moving, preserving nerve function without reducing tumor shrinkage; a non-hallucinogenic analog targeting the same pathway also provided protection, suggesting potential for preventing neuropathy in cancer patients.